Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver function and drug safety: new study on venglustat

NCT ID NCT05718258

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times

Summary

This study looked at how the drug venglustat behaves in people with different levels of liver function. 26 adults with mild, moderate, or severe liver impairment, plus healthy volunteers, received a single dose. Researchers measured drug levels in the blood and monitored safety to understand how liver problems affect the drug's processing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • American Research Corporation Site Number : 8400005

    San Antonio, Texas, 78215, United States

  • Clinical Pharmacology of Miami Site Number : 8400002

    Miami, Florida, 33014, United States

  • Inland Empire Liver Foundation Site Number : 8400004

    Rialto, California, 92377, United States

  • Investigational Site Number : 2760001

    Kiel, 24105, Germany

  • Nucleus Network Site Number : 8400001

    Saint Paul, Minnesota, 55114, United States

  • Volunteer Research Group-NOCCR Site Number : 8400003

    Knoxville, Tennessee, 37920, United States

Conditions

Explore the condition pages connected to this study.